IPP Bureau
Domestic and emerging markets will drive pharma growth: ICRA
By IPP Bureau - January 04, 2022
Healthy growth in domestic and emerging markets is expected to support revenue growth in the next few quarters
Dr Reddy’s molnupiravir priced at Rs 1,400 for a course
By IPP Bureau - January 04, 2022
Molflu is expected to be available from early next week in pharmacies throughout the country with a particular focus on states with a high caseload of Covid-19.
Yokogawa invests in glycan production company GlyTech
By IPP Bureau - January 04, 2022
Partnering to build biosynthesis processes and a pharmaceutical production platform
Emcure to launch oral Covid-19 drug soon
By IPP Bureau - January 03, 2022
A toll-free helpline to be set up to help doctors and patients
Novavax submits data to U.S. FDA for Covid-19 EUA
By IPP Bureau - January 03, 2022
Emergency Use Authorisation application request to be submitted following one month required by FDA EUA guidance
Ascletis expands ritonavir oral tablet production
By IPP Bureau - January 03, 2022
ASC10 is an oral direct-acting antiviral drug candidate targeting RNA dependent RNA polymerase (RdRp) to treat SARS-CoV-2 infection
Snapdeal to promote Ayushman Bharat Digital Mission’s Heath ID
By IPP Bureau - January 03, 2022
The Health ID will allow users to connect with different healthcare providers and enable a consent-based sharing of personal health records
U.S. FDA grants EUA for Pfizer-BioNTech booster for 12 years and older
By IPP Bureau - January 03, 2022
First emergency use authorization in the United States for a Covid-19 vaccine booster in adolescents 12 through 15 years of age
Tan Thanh Holdings to pre-purchase 10 million doses of Covid-19 oral vaccines for ASEAN region
By IPP Bureau - December 30, 2021
Oravax's oral VLP vaccine in development targets three SARS CoV-2 virus surface proteins, including proteins less susceptible to mutation, thus making the vaccine potentially more effective against current and future variants of the Covid-19 virus
Comar expands packaging solutions with Omega acquisition
By IPP Bureau - December 30, 2021
The combination enhances Comar's customer value proposition by adding complementary closure and jar products and related precision mold-making expertise
Quidel’s Antigen tests can detect Omicron variant
By IPP Bureau - December 30, 2021
The QuickVue antigen tests are able to detect the live Omicron variant with similar performance as with other variants
Biological E gets nod to study Corbevax as a booster dose
By IPP Bureau - December 30, 2021
The Subject Expert Committee has recommended grant of permission to conduct Phase 3 trials under certain conditions
VivaLyf Innovations to launch EzLyf, India's first non-invasive glucometer
By IPP Bureau - December 30, 2021
The glucometer connects to one’s smartphone and provides actionable diagnostic information
Green ChemisTree Foundation announces virtual conference on Innovations in Green & Sustainable Chemistry for Pharma Industry
By IPP Bureau - December 30, 2021
Aim of the virtual conference is to facilitate Indian Pharma Industry adopt Green & Sustainable Chemistry as a tool to enhance Economic & Environmental Competitiveness
Merck awarded €121 million contract for flow membrane production facility in Wisconsin, USA
By IPP Bureau - December 30, 2021
The contract award from the U.S. Department of Defense (DoD), on behalf of the U.S. Department of Health and Human Services, is part of an effort to ensure secure local supply and production capacity for critical products for pandemic preparedness
